ATE426167T1 - Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs - Google Patents
Auto-antikírper gegen annexin-proteine als marker fur lungenkrebsInfo
- Publication number
- ATE426167T1 ATE426167T1 AT06075982T AT06075982T ATE426167T1 AT E426167 T1 ATE426167 T1 AT E426167T1 AT 06075982 T AT06075982 T AT 06075982T AT 06075982 T AT06075982 T AT 06075982T AT E426167 T1 ATE426167 T1 AT E426167T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- lung cancer
- antibodies against
- annexin proteins
- auto antibodies
- Prior art date
Links
- 102000000412 Annexin Human genes 0.000 title abstract 2
- 108050008874 Annexin Proteins 0.000 title abstract 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/370,337 US6645465B2 (en) | 1999-08-06 | 1999-08-06 | Annexin proteins and autoantibodies as serum markers for cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE426167T1 true ATE426167T1 (de) | 2009-04-15 |
Family
ID=23459219
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00952594T ATE326699T1 (de) | 1999-08-06 | 2000-08-04 | Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs |
AT09151524T ATE529751T1 (de) | 1999-08-06 | 2000-08-04 | Annexine als marker für lungenkrebs |
AT06075982T ATE426167T1 (de) | 1999-08-06 | 2000-08-04 | Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00952594T ATE326699T1 (de) | 1999-08-06 | 2000-08-04 | Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs |
AT09151524T ATE529751T1 (de) | 1999-08-06 | 2000-08-04 | Annexine als marker für lungenkrebs |
Country Status (10)
Country | Link |
---|---|
US (5) | US6645465B2 (de) |
EP (3) | EP1200832B1 (de) |
JP (1) | JP4594575B2 (de) |
AT (3) | ATE326699T1 (de) |
AU (1) | AU780772B2 (de) |
CA (1) | CA2380398C (de) |
DE (2) | DE60041839D1 (de) |
DK (2) | DK1734368T3 (de) |
ES (2) | ES2320585T3 (de) |
WO (1) | WO2001011372A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810040D0 (en) * | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
US6645465B2 (en) * | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
DE60138111D1 (de) * | 2000-07-21 | 2009-05-07 | Chemo Sero Therapeut Res Inst | Verfahren zur reinigung eines kalziumionen-bindenden proteins |
US7645739B2 (en) | 2001-02-21 | 2010-01-12 | Alavita Pharmaceuticals, Inc. | Modified annexin compositions and methods of using same |
EP1379266B1 (de) | 2001-02-21 | 2007-04-18 | SurroMed, Inc. | Modifizierte annexin-proteine und verhinderung und behandlung von thrombose |
US7635676B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
US7214498B2 (en) * | 2001-03-23 | 2007-05-08 | Benaroya Research Institute At Virginia Mason | Tumor associated antigens and methods of using the same |
WO2003025568A2 (de) * | 2001-09-14 | 2003-03-27 | Reinhard Zeidler | Identifizierung von antigenen durch xenogene, allogene oder autologe antikörper-vermittelte präzipitation |
US20050221305A1 (en) * | 2001-11-09 | 2005-10-06 | Benaroya Research Institute At Virginia Mason | Antigen panels and methods of using the same |
GB2424070B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Methods for preparing tumour marker proteins |
EP2295976A1 (de) | 2003-03-08 | 2011-03-16 | Auvation Ltd | Marker für Darmkrebs |
PL1720611T3 (pl) * | 2004-02-16 | 2010-09-30 | Proteosys Ag | Marker diagnostyczny dla raka |
US8293522B2 (en) * | 2004-05-13 | 2012-10-23 | Centre National De La Recherche Scientifique | Device for binding a target entity to a bait entity and detection methods using the same |
US20060024757A1 (en) * | 2004-07-30 | 2006-02-02 | Robert Hussa | Detection of oncofetal fibronectin for selection of concepti |
RU2277242C2 (ru) * | 2004-08-23 | 2006-05-27 | Александр Владимирович Балюра | Способ диагностики опухолей |
JP4521575B2 (ja) * | 2005-03-17 | 2010-08-11 | 国立大学法人 千葉大学 | 特発性肺線維症の検出マーカー、検出キット及び検出方法 |
EP1724585A1 (de) * | 2005-05-21 | 2006-11-22 | ProteoSys AG | Annexin für Krebsrisikofeststellung |
EP1724586A3 (de) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin für Krebsrisikomanagement |
GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
RU2636532C2 (ru) | 2005-05-27 | 2017-11-23 | Онкиммьюн Лимитед | Улучшенные способы иммуноанализа |
US20060286074A1 (en) * | 2005-05-31 | 2006-12-21 | Yucheng Tang | Methods for immunotherapy of cancer |
US8999727B2 (en) * | 2005-09-26 | 2015-04-07 | Ulrich Loos | Innovative TSH-R-Ab-kit |
CA2632190A1 (en) * | 2005-11-10 | 2007-07-12 | University Of Kentucky | Lung cancer diagnostic assay |
US9347945B2 (en) * | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
EP2041569A4 (de) * | 2006-07-08 | 2009-11-18 | Univ Kentucky Res Found | Assay zur diagnose von lungenkrebs |
US8574848B2 (en) * | 2006-09-13 | 2013-11-05 | Oncimmune Ltd. | Immunoassay methods |
US20080305512A1 (en) * | 2006-10-26 | 2008-12-11 | Mattingly Phillip G | Assay for cardiac troponin autoantibodies |
US7776605B2 (en) | 2006-10-26 | 2010-08-17 | Abbott Laboratories | Assay for cardiac troponin autoantibodies |
WO2008051762A2 (en) * | 2006-10-26 | 2008-05-02 | Abbott Laboratories | Immunoassay of analytes in samples containing endogenous anti-analyte antibodies |
US20090047689A1 (en) * | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
CA2725548A1 (en) * | 2008-05-09 | 2009-11-12 | Duke University | Autoantibodies in the detection and treatment of cancer |
US9581599B2 (en) | 2010-06-28 | 2017-02-28 | The Board Of Regents Of The University Of Texas System | Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2 |
US9555074B2 (en) | 2010-10-08 | 2017-01-31 | Regents Of The University Of Minnesota | Annexin II compositions |
KR20150010882A (ko) * | 2013-07-19 | 2015-01-29 | 삼성전자주식회사 | 아넥신 A2 결합단백질, p53 단백질 및 p18 단백질을 포함하는 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 조성물 |
JP6588893B2 (ja) * | 2013-09-18 | 2019-10-09 | アデレード リサーチ アンド イノベイション ピーティーワイ エルティーディーAdelaide Research & Innovation Pty Ltd | 卵巣がんの自己抗体バイオマーカー |
ES2928331T3 (es) | 2013-11-13 | 2022-11-17 | Univ Minnesota | Composiciones de variantes de anexina II y métodos |
CN104407151B (zh) * | 2014-11-19 | 2016-06-08 | 汕头大学医学院 | Kindlin-2,Myosin-9和Annexin II三蛋白联合预测食管鳞癌患者预后试剂盒 |
CN113721021B (zh) * | 2021-09-16 | 2023-07-07 | 郑州大学 | Prkcz自身抗体在食管鳞癌辅助诊断中的应用 |
CN116539885B (zh) * | 2023-07-06 | 2023-09-29 | 上海秤信生物科技有限公司 | 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02496A (ja) * | 1987-12-24 | 1990-01-05 | Nippon Shinyaku Co Ltd | モノクローナル抗体、製法、及び利用法 |
DE4012341A1 (de) * | 1990-04-18 | 1991-10-24 | Behringwerke Ag | Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung |
DE4040306A1 (de) | 1990-12-17 | 1992-06-25 | Behringwerke Ag | Verfahren zur bestimmung von antikoerpern gegen lipocortine |
US5405749A (en) * | 1991-12-06 | 1995-04-11 | Polans; Arthur S. | Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen |
JPH0772149A (ja) * | 1993-06-30 | 1995-03-17 | Nippon Shinyaku Co Ltd | 肝癌又は肝硬変の診断薬及び診断法 |
JPH0772147A (ja) * | 1993-07-02 | 1995-03-17 | Noboru Kaneko | 抗アネキシンv抗体並びに該抗体の製法及び利用 |
EP0651253A1 (de) * | 1993-11-02 | 1995-05-03 | Abbott Laboratories | Immunoassay zum Nachweis menschlicher Autoantikörper |
US5658877A (en) * | 1995-05-18 | 1997-08-19 | Wisconsin Alumni Research Foundation | Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein |
DK0991945T4 (da) | 1997-06-26 | 2008-06-09 | Univ Michigan | Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum |
US20030064406A1 (en) * | 1997-10-08 | 2003-04-03 | Noboru Kaneko | Process for analyzing annexin-V in urine, and application thereof |
JP2003529318A (ja) * | 1998-12-28 | 2003-10-07 | プロ ダクト ヘルス インコーポレーティッド | 乳管から材料を採取するための装置、方法、およびシステム |
US6645465B2 (en) * | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
-
1999
- 1999-08-06 US US09/370,337 patent/US6645465B2/en not_active Expired - Lifetime
-
2000
- 2000-08-04 CA CA2380398A patent/CA2380398C/en not_active Expired - Fee Related
- 2000-08-04 AT AT00952594T patent/ATE326699T1/de not_active IP Right Cessation
- 2000-08-04 DK DK06075982T patent/DK1734368T3/da active
- 2000-08-04 JP JP2001515976A patent/JP4594575B2/ja not_active Expired - Fee Related
- 2000-08-04 DK DK00952594T patent/DK1200832T3/da active
- 2000-08-04 WO PCT/US2000/021514 patent/WO2001011372A1/en active IP Right Grant
- 2000-08-04 AT AT09151524T patent/ATE529751T1/de not_active IP Right Cessation
- 2000-08-04 ES ES06075982T patent/ES2320585T3/es not_active Expired - Lifetime
- 2000-08-04 AT AT06075982T patent/ATE426167T1/de not_active IP Right Cessation
- 2000-08-04 AU AU65262/00A patent/AU780772B2/en not_active Ceased
- 2000-08-04 ES ES00952594T patent/ES2259609T3/es not_active Expired - Lifetime
- 2000-08-04 DE DE60041839T patent/DE60041839D1/de not_active Expired - Lifetime
- 2000-08-04 EP EP00952594A patent/EP1200832B1/de not_active Expired - Lifetime
- 2000-08-04 DE DE60028040T patent/DE60028040T2/de not_active Expired - Lifetime
- 2000-08-04 EP EP06075982A patent/EP1734368B1/de not_active Expired - Lifetime
- 2000-08-04 EP EP09151524A patent/EP2051079B1/de not_active Expired - Lifetime
-
2003
- 2003-09-05 US US10/656,356 patent/US20040048320A1/en not_active Abandoned
-
2006
- 2006-06-21 US US11/425,528 patent/US7759081B2/en not_active Expired - Fee Related
- 2006-06-21 US US11/425,439 patent/US20060275845A1/en not_active Abandoned
-
2010
- 2010-06-10 US US12/813,070 patent/US7955602B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4594575B2 (ja) | 2010-12-08 |
AU6526200A (en) | 2001-03-05 |
DE60028040D1 (de) | 2006-06-22 |
EP2051079A3 (de) | 2009-06-10 |
CA2380398C (en) | 2017-01-31 |
US7955602B2 (en) | 2011-06-07 |
ATE529751T1 (de) | 2011-11-15 |
WO2001011372A1 (en) | 2001-02-15 |
AU780772B2 (en) | 2005-04-14 |
EP1734368B1 (de) | 2009-03-18 |
US20070037227A1 (en) | 2007-02-15 |
DE60028040T2 (de) | 2006-11-23 |
EP1200832B1 (de) | 2006-05-17 |
EP1734368A2 (de) | 2006-12-20 |
US7759081B2 (en) | 2010-07-20 |
JP2003535309A (ja) | 2003-11-25 |
US20040048320A1 (en) | 2004-03-11 |
EP1200832A1 (de) | 2002-05-02 |
DK1200832T3 (da) | 2006-09-18 |
DK1734368T3 (da) | 2009-06-02 |
ES2320585T3 (es) | 2009-05-25 |
US20020168696A1 (en) | 2002-11-14 |
EP2051079B1 (de) | 2011-10-19 |
US20060275845A1 (en) | 2006-12-07 |
CA2380398A1 (en) | 2001-02-15 |
EP2051079A2 (de) | 2009-04-22 |
ATE326699T1 (de) | 2006-06-15 |
ES2259609T3 (es) | 2006-10-16 |
US6645465B2 (en) | 2003-11-11 |
DE60041839D1 (de) | 2009-04-30 |
US20100330587A1 (en) | 2010-12-30 |
WO2001011372A9 (en) | 2002-04-11 |
EP1734368A3 (de) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE426167T1 (de) | Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs | |
ATE246361T1 (de) | Verfahren zur bestimmung von ige | |
DK0991421T3 (da) | Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom | |
DE69636075D1 (de) | Verbindungen und verfahren zur diagnose von tuberkulose | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
LU91756I2 (fr) | Denosumab | |
TR200000113T2 (tr) | Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri. | |
DE69941688D1 (de) | Immunoassays unter verwendung von sers (surface enhanced raman scattering) | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
ATE328280T1 (de) | Verfahren und zusammensetzungen zur karzinomdiagnose | |
ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
WO2005019831B1 (en) | Methods for reducing complexity of a sample using small epitope antibodies | |
ATE422671T1 (de) | Verfahren zur diagnose von morbus alzheimer | |
ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
ATE534907T1 (de) | Verfahren für den nachweis von l523s-expression in biologischen proben | |
ATE421693T1 (de) | Proteine in der diabetes-proteomanalyse | |
ATE208040T1 (de) | Immunoassay-reagenzien, testsätze und verfahren | |
Paterson et al. | High throughput flow cytometry for cell surface profiling | |
EP1677115A3 (de) | Prion-Assays mit hoher Durchlaufleistung | |
DE60311278D1 (de) | Immunochromatographiesystem und verfahren zur gleichzeitigen identifikation von aga-und t-tg-antikörpern und verwendung dafür zur diagnose der zöliakiekrankheit | |
FR2786787B1 (fr) | Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques | |
ATE347108T1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
CN117054385A (zh) | 一种高通量蛋白荧光标记方法 | |
DE59906849D1 (de) | Verfahren zum spezifischen Nachweis von glykosilierten Proteinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |